Position in GKOS
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$38,457,898
+$4,111,452 QoQ
Shares Held
275,171
-13.7% QoQ
Ownership
0.467%
of shares outstanding
% of Portfolio
0.99%
of 13F equity value
Holder Rank
#48
of 364 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 94%
Shared 0%
None 6%
Common Shares in GKOS Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Champlain Investment Partners, LLC holds $272,827,470 across 10 Medical Devices names. GKOS ranks #2 (14.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PEN |
Penumbra Inc
|
219,032 | $69,159,354 | |
| 2 | GKOS |
GLAUKOS Corp
This page
|
275,171 | $38,457,898 | |
| 3 | EW |
Edwards Lifesciences Corp
|
346,640 | $31,357,054 | |
| 4 | STE |
STERIS plc
|
109,230 | $23,000,561 | |
| 5 | GMED |
Globus Medical Inc
|
290,878 | $22,982,270 | |
| 6 | PRCT |
PROCEPT BioRobotics Corp
|
981,381 | $22,159,582 | |
| 7 | BRKR |
Bruker Corp
|
355,746 | $21,408,794 | |
| 8 | DXCM |
Dexcom Inc
|
269,217 | $18,131,764 |
All Filings in GKOS
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $38,457,898 | 275,171 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $34,346,446 | 319,027 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $37,628,838 | 333,264 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $29,229,069 | 358,419 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $37,496,955 | 363,026 | Shares | Sole | 2025-08-12 | |
| No filing history on record for this holder in this stock. | ||||||